CVS HEALTH CORPORATION Related Party Transaction, Other Revenues from Transactions with Related Party
CVS HEALTH CORPORATION (CVS) reported Related Party Transaction, Other Revenues from Transactions with Related Party of $19.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Income Statement › Other Income
us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty · last filed 2023-05-25
- CVS HEALTH CORPORATION related party transaction, other revenues from transactions with related party for the quarter ending 2023-03-31 was $19.00M, a 9.52% decline year-over-year.
- CVS HEALTH CORPORATION related party transaction, other revenues from transactions with related party for the quarter ending 2022-12-31 was $21.00M, a 4.55% decline year-over-year.
- CVS HEALTH CORPORATION related party transaction, other revenues from transactions with related party for the quarter ending 2022-09-30 was $22.00M, a 10.00% increase year-over-year.
- CVS HEALTH CORPORATION related party transaction, other revenues from transactions with related party for the quarter ending 2022-06-30 was $23.00M, a 21.05% increase year-over-year.
- CVS HEALTH CORPORATION related party transaction, other revenues from transactions with related party for fiscal 2019 was $96.00M, a 28.89% decline from fiscal 2018.
- CVS HEALTH CORPORATION related party transaction, other revenues from transactions with related party for fiscal 2018 was $135.00M, a 2.88% decline from fiscal 2017.
- CVS HEALTH CORPORATION related party transaction, other revenues from transactions with related party for fiscal 2017 was $139.00M.
| Period end | Related Party Transaction, Other Revenues from Transactions with Related Party 3 month | Related Party Transaction, Other Revenues from Transactions with Related Party 6 month | Related Party Transaction, Other Revenues from Transactions with Related Party 9 month | Related Party Transaction, Other Revenues from Transactions with Related Party 12 month |
|---|---|---|---|---|
| 2023-03-31 | $19.00M 10-Q · filed 2023-05-03 | $40.00M derived: sum of 2 quarters · filed 2023-05-25 | $62.00M derived: sum of 3 quarters · filed 2023-05-25 | $85.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2022-12-31 | $21.00M derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $43.00M derived: sum of 2 quarters · filed 2023-05-25 | $66.00M derived: sum of 3 quarters · filed 2023-05-25 | $87.00M 8-K · filed 2023-05-25 |
| 2022-09-30 | $22.00M 10-Q · filed 2022-11-02 | $45.00M derived: sum of 2 quarters · filed 2022-11-02 | $66.00M 10-Q · filed 2022-11-02 | $88.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2022-06-30 | $23.00M 10-Q · filed 2022-08-03 | $44.00M 10-Q · filed 2022-08-03 | $66.00M derived: sum of 3 quarters · filed 2023-05-25 | $86.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2022-03-31 | $21.00M 10-Q · filed 2023-05-03 | $43.00M derived: sum of 2 quarters · filed 2023-05-25 | $63.00M derived: sum of 3 quarters · filed 2023-05-25 | $82.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-12-31 | $22.00M derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $42.00M derived: sum of 2 quarters · filed 2023-05-25 | $61.00M derived: sum of 3 quarters · filed 2023-05-25 | $79.00M 8-K · filed 2023-05-25 |
| 2021-09-30 | $20.00M 10-Q · filed 2022-11-02 | $39.00M derived: sum of 2 quarters · filed 2022-11-02 | $57.00M 10-Q · filed 2022-11-02 | $76.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-06-30 | $19.00M 10-Q · filed 2022-08-03 | $37.00M 10-Q · filed 2022-08-03 | $56.00M derived: sum of 3 quarters · filed 2023-05-25 | $71.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2021-03-31 | $18.00M 10-Q · filed 2022-05-04 | $37.00M derived: sum of 2 quarters · filed 2023-05-25 | $52.00M derived: sum of 3 quarters · filed 2023-05-25 | $74.00M derived: sum of 4 quarters · filed 2023-05-25 |
| 2020-12-31 | $19.00M derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25 | $34.00M derived: sum of 2 quarters · filed 2023-05-25 | $56.00M derived: sum of 3 quarters · filed 2023-05-25 | $77.00M 8-K · filed 2023-05-25 |
| 2020-09-30 | $15.00M 10-Q · filed 2021-11-03 | $37.00M derived: sum of 2 quarters · filed 2021-11-03 | $58.00M 10-Q · filed 2021-11-03 | $82.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $22.00M 10-Q · filed 2021-08-04 | $43.00M 10-Q · filed 2021-08-04 | $67.00M derived: sum of 3 quarters · filed 2022-02-09 | $87.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $21.00M 10-Q · filed 2021-05-04 | $45.00M derived: sum of 2 quarters · filed 2022-02-09 | $65.00M derived: sum of 3 quarters · filed 2022-02-09 | $92.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $44.00M derived: sum of 2 quarters · filed 2022-02-09 | $71.00M derived: sum of 3 quarters · filed 2022-02-09 | $96.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $20.00M 10-Q · filed 2020-11-06 | $47.00M derived: sum of 2 quarters · filed 2020-11-06 | $72.00M 10-Q · filed 2020-11-06 | $102.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $27.00M 10-Q · filed 2020-08-05 | $52.00M 10-Q · filed 2020-08-05 | $82.00M derived: sum of 3 quarters · filed 2021-02-16 | $116.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $25.00M 10-Q · filed 2020-05-06 | $55.00M derived: sum of 2 quarters · filed 2021-02-16 | $89.00M derived: sum of 3 quarters · filed 2021-02-16 | $125.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $64.00M derived: sum of 2 quarters · filed 2021-02-16 | $100.00M derived: sum of 3 quarters · filed 2021-02-16 | $135.00M 10-K · filed 2021-02-16 |
| 2018-09-30 | $34.00M 10-Q · filed 2019-11-06 | $70.00M derived: sum of 2 quarters · filed 2019-11-06 | $105.00M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $36.00M 10-Q · filed 2019-08-07 | $71.00M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $35.00M 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $139.00M 10-K · filed 2020-02-18 | |||
| 2016-12-31 | $140.00M 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |